Amrutanjan Health Care Limited (NSE:AMRUTANJAN)

Amrutanjan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	4,621	4,518	4,212	3,796	4,058	3,328
Other Revenue	1.47	1.47	1.41	1.23	1.06	1.69
Revenue	4,623	4,520	4,214	3,798	4,059	3,330
Revenue Growth (YoY)	8.23%	7.26%	10.96%	-6.45%	21.90%	27.23%
Cost of Revenue	2,343	2,289	2,170	1,874	1,838	1,432
Gross Profit	2,280	2,230	2,043	1,924	2,221	1,899
Selling, General & Admin	604.71	597.16	484.02	492.2	484.84	420.53
Other Operating Expenses	1,028	1,035	1,026	960	879.76	647.2
Operating Expenses	1,697	1,698	1,571	1,505	1,423	1,181
Operating Income	582.14	532.59	472.47	418.55	798.41	717.93
Interest Expense	-2.06	-2.19	-1.57	-0.77	-4.85	-5
Interest & Investment Income	160.47	160.47	148.05	117.83	111.7	93.88
Currency Exchange Gain (Loss)	0.26	0.26	0.62	2.38	1.25	0.59
Other Non Operating Income (Expenses)	-0.06	0.19	0.69	0.24	0.83	0.42
EBT Excluding Unusual Items	740.76	691.32	620.26	538.23	907.34	807.82
Gain (Loss) on Sale of Investments	0.02	0.02	-1.26	-2.05	-1.57	-3.67
Gain (Loss) on Sale of Assets	-	-	1.57	0.27	-	0.89
Asset Writedown	-	-	-1.11	-	-	-
Pretax Income	740.78	691.34	619.46	536.45	905.77	819.05
Income Tax Expense	195.48	182.99	169.73	138.11	233.88	207.14
Earnings From Continuing Operations	545.3	508.35	449.73	398.35	671.89	611.9
Net Income	545.3	508.35	449.73	398.35	671.89	611.9
Net Income to Common	545.3	508.35	449.73	398.35	671.89	611.9
Net Income Growth	28.08%	13.04%	12.90%	-40.71%	9.80%	143.95%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
Shares Change (YoY)	0.07%	-0.38%	-0.71%	-0.03%	0.00%	0.02%
EPS (Basic)	18.84	17.58	15.50	13.65	23.00	20.94
EPS (Diluted)	18.84	17.58	15.50	13.63	22.98	20.93
EPS Growth	27.98%	13.44%	13.70%	-40.69%	9.79%	143.94%
Free Cash Flow	-	153.46	211.93	112.54	287.32	889.09
Free Cash Flow Per Share	-	5.31	7.30	3.85	9.83	30.41
Dividend Per Share	-	4.600	4.600	4.600	4.600	4.200
Dividend Growth	-	-	-	-	9.52%	281.82%
Gross Margin	49.31%	49.35%	48.49%	50.65%	54.72%	57.01%
Operating Margin	12.59%	11.78%	11.21%	11.02%	19.67%	21.56%
Profit Margin	11.80%	11.25%	10.67%	10.49%	16.55%	18.38%
Free Cash Flow Margin	-	3.40%	5.03%	2.96%	7.08%	26.70%
EBITDA	637.59	584.69	520.33	458.66	830.49	747.3
EBITDA Margin	13.79%	12.94%	12.35%	12.08%	20.46%	22.44%
D&A For EBITDA	55.45	52.1	47.86	40.11	32.09	29.37
EBIT	582.14	532.59	472.47	418.55	798.41	717.93
EBIT Margin	12.59%	11.78%	11.21%	11.02%	19.67%	21.56%
Effective Tax Rate	26.39%	26.47%	27.40%	25.74%	25.82%	25.29%
Revenue as Reported	4,798	4,695	4,376	3,942	4,212	3,442

Source: S&P Global Market Intelligence. Standard template. Financial Sources.